Rebus Holdings, Inc. (RBSH)

0.0000 0.00 (0.00%) USD  |  OTCM  |  Oct 02, 16:00
More

Rebus Holdings Cash from Operations (TTM)

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2023 -0.26M
March 31, 2023 -0.582M
December 31, 2022 -0.706M
September 30, 2022 -0.861M
June 30, 2022 -0.865M
March 31, 2022 -0.671M
December 31, 2021 -0.693M
September 30, 2021 -0.538M
June 30, 2021 -0.486M
March 31, 2021 -0.393M
December 31, 2020 -0.374M
September 30, 2020 -0.272M
June 30, 2020 -0.368M
March 31, 2020 -0.38M
December 31, 2019 -0.313M
September 30, 2019 -0.329M
June 30, 2019 -0.305M
March 31, 2019 -0.261M
December 31, 2018 -0.204M
September 30, 2018 -0.169M
June 30, 2018 -0.275M
March 31, 2018 -0.389M
December 31, 2017 -1.092M
September 30, 2017 -1.682M
June 30, 2017 -2.017M
Date Value
March 31, 2017 -2.532M
December 31, 2016 -2.733M
September 30, 2016 -3.148M
June 30, 2016 -3.694M
March 31, 2016 -4.344M
December 31, 2015 -4.633M
September 30, 2015 -4.863M
June 30, 2015 -4.951M
March 31, 2015 -5.231M
December 31, 2014 -5.044M
September 30, 2014 -5.079M
June 30, 2014 -5.129M
March 31, 2014 -4.706M
December 31, 2013 -4.707M
September 30, 2013 -4.476M
June 30, 2013 -4.658M
March 31, 2013 -4.487M
December 31, 2012 -4.521M
September 30, 2012 -4.598M
June 30, 2012 -4.396M
March 31, 2012 -4.454M
December 31, 2011 -3.744M
September 30, 2011 -3.458M
June 30, 2011 -2.787M
March 31, 2011 -2.703M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 160.32M
Alnylam Pharmaceuticals, Inc. 885.89M
Savara, Inc. -110.38M
Vericel Corp. 69.67M
Biogen, Inc. 2.879B